Combined Retinoic Acid,Arsenic Trioxide and Chemo for Newly-diagnosed APL

NCT01987297 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

738

Enrollment

OTHER

Sponsor class

Conditions

Acute Promyelocytic Leukemia

Interventions

DRUG: ATRA+Arsenic
DRUG: ATRA+Chemo

Sponsor

Shanghai Jiao Tong University School of Medicine

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]